Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 14 (8), 463

Botulinum Toxin for Symptomatic Therapy in Multiple Sclerosis

Affiliations
Review

Botulinum Toxin for Symptomatic Therapy in Multiple Sclerosis

Michelle H Cameron et al. Curr Neurol Neurosci Rep.

Abstract

Botulinum toxin (BT) is a neurotoxin that paralyzes muscles by inhibiting release of acetylcholine from presynaptic vesicles at the neuromuscular junction. In people with multiple sclerosis (MS), clinical experience and research studies show that local injection of minute quantities of BT can temporarily control skeletal muscle spasticity, bladder detrusor hyperreflexia, and tremor. Specifically, BT injections have been shown to reduce muscle tone and improve passive function, and possibly improve active function, in patients with spasticity. Injection of BT into the bladder wall is a uniquely effective, safe, and durable treatment in patients with neurogenic detrusor hyperreflexia due to MS who have insufficient response or who do not tolerate oral antimuscarinic medications. This procedure has markedly reduced the need for indwelling catheters and bladder surgery. In addition, a recent study suggests BT may be effective for select patients with MS-associated upper extremity tremor. Appropriate use of BT can improve quality of life for many patients with MS.

Similar articles

See all similar articles

Cited by 8 articles

See all "Cited by" articles

References

    1. Clin Rehabil. 2014 Mar;28(3):232-42 - PubMed
    1. Prog Urol. 2012 Dec;22(17):1064-70 - PubMed
    1. Eur J Neurol. 1997 Jan;4(1):68-71 - PubMed
    1. J Urol. 2012 Jun;187(6):2131-9 - PubMed
    1. J Urol. 1999 Mar;161(3):743-57 - PubMed

MeSH terms

LinkOut - more resources

Feedback